ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/02/24
Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination DevelopmentGlobeNewsWire • 12/11/23
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational UpdatesGlobeNewsWire • 11/06/23
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/02/23
Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class ProfileGlobeNewsWire • 10/21/23
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023GlobeNewsWire • 10/17/23
Oric Pharmaceuticals, Inc. (ORIC) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 10/16/23
ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare ConferenceGlobeNewsWire • 09/20/23
ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational UpdatesGlobeNewsWire • 08/10/23
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational UpdatesGlobeNewsWire • 05/08/23
ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor ConferenceGlobeNewsWire • 04/25/23
ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/18/23
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational UpdatesGlobeNewsWire • 03/16/23
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 03/14/23
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewsWire • 03/06/23
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming MilestonesGlobeNewsWire • 01/09/23